SMi’s Biomarkers in Clinical Trials conference will present attendees with new concepts in biomarker application as well as a comprehensive review of recent developments. This unique event will bring together academics and industry professionals in order to provide a complete picture. There will be a strong focus on using biomarkers to bridge the gap between basic and applied research in drug development.

Presentations will contain examples of biomarker application in the development of treatments for conditions in different therapeutic areas including oncology, nephrology, neurology and cardiology. Attendees will have the opportunity to network with industry associates and discuss the way forward in translational research and personalised medicine.

Why should you attend this event?

• Hear case studies relating to the use of translational biomarkers
• Identify ways of combining clinical, imaging and tissue biomarkers
• Explore the potential of next-generation sequencing technologies
• Discover the advantages of efficacy biomarkers in exploratory development
• Discuss the potential of microRNA as a biomarker for drug efficacy

PLUS a Half-Day Post-Conference Workshop on Commercialisation of Biomarkers for Personalised Medicine In association with: Permedx Wednesday 22nd September 2010, Hilton London Kensington Hotel